Best Treatments for Functional Abdominal Pain (Centrally Mediated Abdominal Pain Syndrome) in 2027

Functional abdominal pain, now classified as centrally mediated abdominal pain syndrome (CAPS) under the Rome V framework (updated May 2026), is one of the most challenging chronic pain conditions to treat. Unlike other gastrointestinal disorders, CAPS involves persistent abdominal pain that is not fully explained by structural or biochemical findings. The pain is real, but its primary driver is the central nervous system, not the gut itself.

Treatment options for CAPS have expanded significantly. Research increasingly points to the role of central sensitization in pain, and the latest Rome V guidelines specifically recommend brain-gut behavioral therapy alongside central neuromodulators as the core treatment approach. This guide covers the most evidence-supported treatments available in 2027, from comprehensive behavioral programs to pharmacological and complementary approaches.

Key Takeaways

• CAPS is classified as a disorder of gut-brain interaction (DGBI) under the Rome V criteria (updated 2026), driven by central sensitization rather than structural gut damage.
• Brain-based behavioral therapies, including CBT, ACT, and gut-directed hypnotherapy, have clinical evidence for reducing pain and disability in functional abdominal pain.
• Central neuromodulators like low-dose tricyclic antidepressants and SNRIs are recommended by the AGA as first-line pharmacological options for CAPS.
• Combining behavioral approaches with medication may produce better outcomes than either alone for adults with moderate-to-severe CAPS.
• Lin Health's brain-based recovery program is built on findings from neuroplastic pain research, delivered by trained coaches, and covered by most major insurance plans.

What Is Functional Abdominal Pain (CAPS)?

Centrally mediated abdominal pain syndrome is a gastrointestinal disorder defined by continuous or frequently recurring abdominal pain that is not related to eating, menstruation, or other physiological events. Under the Rome V classification00117-4/fulltext) (updated May 2026, replacing Rome IV), CAPS falls within the broader category of disorders of gut-brain interaction (DGBI). Rome V moves away from the term "functional" wherever possible, reflecting the understanding that these are real, measurable disorders of brain-gut signaling.

What distinguishes CAPS from conditions like irritable bowel syndrome or functional dyspepsia is the absence of a clear peripheral trigger. Standard GI evaluations, including endoscopies, imaging, and lab work, typically come back normal. That does not mean the pain is imagined. It means the pain is amplified centrally.

The underlying mechanism involves central sensitization, a process in which the brain and spinal cord become hypersensitive to pain signals. In adults with CAPS, the nervous system's pain alarm becomes "stuck," continuing to fire even without tissue damage or inflammation in the gut. This is the same nociplastic pain mechanism now recognized by the International Association for the Study of Pain (IASP) across many chronic pain conditions.

CAPS is relatively uncommon compared to IBS, with prevalence estimates in the range of 0.5% to 1.7% of the general population. However, it is widely considered underdiagnosed because many patients cycle through years of testing and specialist visits before receiving an accurate diagnosis.

Risk factors include:

• Chronic stress or trauma history that may sensitize the nervous system over time
• Co-occurring anxiety or depression, which share overlapping neural pathways with chronic pain
• Prior gastrointestinal illness or surgery that initially triggered pain, even if the original condition has resolved
• Other centrally mediated pain conditions such as fibromyalgia, chronic pelvic pain, or chronic headache

Understanding that CAPS is a brain-driven condition, not a gut-driven one, is the starting point for choosing effective treatment. The therapies below reflect that understanding.

1. Brain-Based Behavioral Recovery Programs

For adults living with CAPS, a structured brain-based recovery program addresses the central sensitization that drives the condition. Rather than targeting the gut, these programs retrain the nervous system's pain response through a combination of evidence-backed behavioral modalities.

How it works

Brain-based programs combine multiple therapeutic approaches, including cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), pain reprocessing therapy (PRT), and somatic tracking, into a single coordinated treatment plan. Instead of learning one technique from one provider, participants work through an integrated curriculum designed to interrupt the pain-fear-avoidance cycle from multiple angles.

What the evidence supports

Each modality within these programs has its own evidence base. Cognitive behavioral therapy reduces pain and disability for adults with chronic pain, with effects generally maintained at follow-up. Acceptance and commitment therapy improves function and acceptance in adults with chronic pain across 21 randomized controlled trials. The integration of multiple modalities may offer broader coverage of the cognitive, emotional, and behavioral dimensions of centrally mediated pain than any single approach alone.

Who it may help

Adults with CAPS who have tried conventional GI treatments without lasting relief. These programs are particularly well-suited for patients whose pain is driven by central sensitization rather than a peripheral structural cause.

What to look for

Look for programs that offer live coaching or therapy sessions (not just self-paced content), are built on peer-reviewed research, accept insurance, and provide access within days rather than weeks. The combination of professional guidance and structured content matters: self-directed approaches to neuroplastic pain have lower completion rates than coached programs.

2. Cognitive Behavioral Therapy (CBT)

CBT is the most extensively studied psychological therapy for chronic pain and functional gastrointestinal disorders. It targets the thought patterns, behaviors, and emotional responses that amplify and maintain pain.

How it works

CBT for CAPS focuses on identifying and modifying pain catastrophizing (expecting the worst outcome), hypervigilance to abdominal sensations, and avoidance behaviors that reinforce the pain cycle. Patients learn to reframe their relationship with pain signals, reduce anticipatory anxiety around meals or activities, and gradually re-engage with daily life.

What the evidence supports

A Cochrane systematic review of 75 studies and over 9,400 participants found that CBT produces beneficial effects on pain in adults with chronic pain, with effects maintained at follow-up. For functional GI disorders specifically, the AGA recommends CBT as a brain-gut behavioral therapy for managing pain in disorders of gut-brain interaction.

A systematic review of CBT for gastroduodenal DGBIs found that while interventions and methodologies varied, the approach is consistently recommended in clinical guidelines for DGBI management.

Who it may help

Adults with CAPS who experience significant pain catastrophizing, fear-avoidance behaviors, or anxiety related to abdominal symptoms. CBT is also effective for patients with co-occurring anxiety or depression, which are common alongside CAPS.

Access considerations

CBT for chronic pain can be delivered in person, via telehealth, or through structured digital programs. Access to GI-specialized CBT therapists remains limited in many areas. The AGA has noted that many qualified providers do not accept insurance, with out-of-pocket costs often reaching $1,000 to $2,000 for a treatment course.

3. Gut-Directed Hypnotherapy

Gut-directed hypnotherapy (GDH) uses guided relaxation and targeted suggestions to reduce visceral hypersensitivity, the heightened pain response from the gut that characterizes many functional GI disorders.

How it works

During GDH sessions, a trained therapist guides the patient into a relaxed, focused state and delivers suggestions aimed at normalizing gut sensation, reducing pain signaling, and restoring a sense of control over abdominal symptoms. Standard protocols typically involve 7 to 12 sessions over several months.

What the evidence supports

A 2025 systematic review and meta-analysis of 16 randomized controlled trials found that gut-directed hypnotherapy reduces IBS symptom severity, with benefits sustained at follow-ups of up to 12 months. A separate 2025 meta-analysis in Neurogastroenterology and Motility confirmed efficacy for IBS symptom reduction.

The evidence base is strongest for IBS rather than CAPS specifically, but the shared mechanism of visceral hypersensitivity and central sensitization makes GDH a reasonable treatment option. The AGA includes gut-directed hypnotherapy alongside CBT as a recommended behavioral therapy for functional GI disorders.

Who it may help

Adults with CAPS who have heightened visceral sensitivity, stress-related symptom flares, or difficulty with traditional talk-based therapies. GDH may be particularly effective for patients who respond well to relaxation-based approaches.

Access considerations

Availability of trained gut-directed hypnotherapists is limited. Digital and app-based GDH programs have emerged, though a multicenter trial found that smartphone-based self-guided hypnotherapy was not non-inferior to in-person therapist-delivered sessions for abdominal pain reduction.

4. Central Neuromodulators (Tricyclic Antidepressants and SNRIs)

Central neuromodulators are the primary pharmacological treatment for CAPS. These medications work on the brain and spinal cord to dampen pain signaling, not on the gut itself.

How they work

Tricyclic antidepressants (TCAs) like amitriptyline and desipramine, and serotonin-norepinephrine reuptake inhibitors (SNRIs) like duloxetine, modulate pain processing in the central nervous system. They are prescribed at doses lower than those used for depression, targeting the descending pain inhibition pathways that are impaired in centrally sensitized conditions.

What the evidence supports

The 2026 Rome V expert review in Gastroenterology recommends neuromodulators for CAPS00117-4/fulltext), noting that patients whose pain is centrally mediated (without a physiological trigger) are more likely to respond. In the largest primary care trial of a TCA for functional GI pain, low-dose amitriptyline nearly doubled symptom improvement01523-4/fulltext) compared with placebo in 463 adults with IBS, with symptom severity scores improving by 99 points versus 69 for placebo. Notably, anxiety and depression scores did not change, suggesting the benefit works through pain modulation rather than mood effects.

Duloxetine specifically has been studied for CAPS, with a clinical study finding that duloxetine improved CAPS symptoms in patients meeting diagnostic criteria. A 2024 ACG review provides guidance on central neuromodulators in functional GI disorders, positioning TCAs as first-line and SNRIs as alternatives.

Who they may help

Adults with moderate-to-severe CAPS, particularly those with co-occurring anxiety, depression, or sleep disturbance. TCAs may be preferred for patients with prominent sleep disruption (due to sedating effects), while SNRIs may be better suited for patients with co-occurring fatigue or musculoskeletal pain.

Important considerations

• Side effects include dry mouth, constipation, drowsiness (TCAs), and nausea (SNRIs)
• Doses are typically lower than those used for mood disorders
• Benefits may take 4 to 6 weeks to emerge
• The AGA recommends discussing the rationale for prescribing an "antidepressant" for pain with patients, since the term can cause confusion
• Opioids are not recommended for CAPS and may worsen centrally mediated pain through opioid-induced hyperalgesia

5. Acceptance and Commitment Therapy (ACT)

ACT takes a different approach from CBT. Rather than trying to change pain-related thoughts, ACT helps patients develop psychological flexibility, the ability to experience pain without letting it dictate behavior or quality of life.

How it works

ACT uses mindfulness, values clarification, and committed action to help patients stop struggling against pain and instead redirect their energy toward what matters most to them. For adults with CAPS, this means learning to have abdominal pain present without catastrophizing, avoiding activities, or withdrawing from life.

What the evidence supports

A 2024 systematic review and meta-analysis of 21 RCTs found that ACT produces meaningful effects on function in adults with chronic pain, both post-treatment and at three-month follow-up. An earlier three-level meta-analysis found ACT superior on symptom outcomes.

ACT has also shown efficacy specifically for fibromyalgia, another centrally sensitized condition that shares overlapping mechanisms with CAPS. A 2026 practice review in Practical Gastroenterology notes that ACT evidence in disorders of gut-brain interaction is "more nascent" for DGBIs, positioning ACT as a promising but still-emerging option for functional GI conditions specifically. Learn more about how acceptance and commitment therapy works within a broader pain recovery framework.

Who it may help

Adults with CAPS who find that pain avoidance, fear, and loss of identity around their condition are significant barriers. ACT may be especially useful for patients who have not responded to traditional CBT, or who feel resistant to the idea of "changing their thoughts" about pain.

6. Pain Reprocessing Therapy (PRT)

Pain reprocessing therapy is a newer approach that directly targets the brain's learned pain response. PRT is built on the premise that in centrally mediated conditions, the brain generates pain as a false danger signal, and that this signal can be "unlearned."

How it works

PRT teaches patients to reappraise their pain as a brain-generated signal rather than evidence of tissue damage. Through techniques like somatic tracking (observing pain sensations with curiosity rather than fear), corrective experiences, and cognitive reappraisal, PRT aims to deactivate the neural pathways maintaining chronic pain.

What the evidence supports

A randomized controlled trial published in JAMA Psychiatry found that PRT produced durable pain relief in adults with chronic back pain. A five-year follow-up of the same trial, published in JAMA Psychiatry in 2025, found that PRT participants maintained significantly lower pain intensity than both placebo and usual care groups, with more than half of those followed remaining nearly or completely pain-free at five years.

Scope note: The PRT evidence comes from a trial in chronic back pain, not CAPS specifically. The conceptual relevance to CAPS lies in the shared mechanism: both conditions involve learned pain patterns in the brain. PRT has not yet been tested in a controlled trial for functional abdominal pain, so its application to CAPS is based on mechanistic reasoning rather than direct evidence.

Who it may help

Adults with CAPS who resonate with the idea that their pain is driven by the brain rather than the gut. PRT may be particularly effective for patients who recognize that fear and hypervigilance around abdominal sensations are maintaining their pain cycle. Guided somatic tracking practices can serve as a starting point.

7. Mindfulness-Based Stress Reduction (MBSR)

MBSR is a structured program that combines mindfulness meditation, body awareness, and gentle movement to help patients relate differently to pain and stress.

How it works

MBSR teaches participants to observe pain sensations without reactivity, reducing the emotional amplification that worsens centrally mediated pain. The standard MBSR protocol involves eight weekly group sessions plus daily home practice. For CAPS, the focus is on interrupting the stress-pain feedback loop in which psychological stress increases visceral sensitivity, which increases anxiety, which increases pain.

What the evidence supports

Research on mindfulness-based interventions for functional GI disorders shows that mindfulness training is associated with decreased sensitivity in patients with IBS, and that this reduction in sensitivity correlates with improved symptom severity and quality of life. Research comparing MBSR with CBT for chronic pain has found comparable outcomes for both over usual care, with no significant difference between the two approaches.

Who it may help

Adults with CAPS in whom stress is a clear amplifier of symptoms. MBSR is widely available through hospital-based wellness programs, community centers, and telehealth platforms, making it one of the more accessible options on this list. It pairs well with other treatments, including medication or individual therapy.

8. Emotional Awareness and Expression Therapy (EAET)

EAET is a newer psychotherapy that focuses on the emotional roots of chronic pain, particularly suppressed, avoided, or unprocessed emotions that may contribute to central sensitization.

How it works

EAET helps patients identify and express emotions, including anger, grief, guilt, and fear, that may be linked to their pain. The therapy draws on research showing that emotional processing and chronic pain share overlapping neural circuits. For adults with CAPS, where trauma history and emotional suppression are common, EAET directly targets the emotional dimension of pain maintenance.

What the evidence supports

A 2024 randomized controlled trial published in JAMA Network Open compared EAET with CBT in older veterans (ages 60 to 95) with chronic musculoskeletal pain. EAET produced greater pain reduction, with 63% of EAET participants achieving at least 30% pain reduction compared with 17% in the CBT group. Effects were sustained at six months.

Scope note: This trial studied older veterans with chronic musculoskeletal pain, not CAPS specifically. The relevance to CAPS is the shared role of emotional processing in central sensitization. EAET has not yet been tested in a controlled trial for functional abdominal pain. Learn more about the rationale behind EAET for chronic pain.

Who it may help

Adults with CAPS who have a history of emotional trauma, suppressed anger or grief, or who sense a connection between their emotional state and symptom flares. EAET may be particularly relevant for patients who have not responded to purely cognitive approaches like standard CBT.

9. Low-Dose Naltrexone (LDN)

Low-dose naltrexone is an emerging pharmacological option for centrally sensitized pain conditions. At standard doses (50 mg), naltrexone blocks opioid receptors. At low doses (1.5 to 4.5 mg), it appears to have anti-inflammatory and pain-modulating effects through a different mechanism.

How it works

LDN is thought to reduce chronic pain by modulating microglial activity in the central nervous system. Microglia are immune cells in the brain that, when chronically activated, contribute to neuroinflammation and central sensitization. By temporarily blocking opioid receptors at low doses, LDN may also trigger a rebound increase in endorphin production.

What the evidence supports

A 2025 meta-analysis of five randomized controlled trials in fibromyalgia, presented at ACR Convergence, found that LDN lowered pain scores compared with placebo. A scoping review of LDN for centralized pain conditions found early-stage evidence of gains in pain severity and function with minimal side effects.

Scope note: There are no published controlled trials of LDN specifically for CAPS or functional abdominal pain. The evidence comes from fibromyalgia and other centrally sensitized conditions. LDN remains off-label for all pain indications. Read more about LDN for chronic pain and the current state of the research.

Who it may help

Adults with CAPS who have not responded adequately to standard neuromodulators (TCAs, SNRIs) and who are interested in pharmacological options with a favorable side-effect profile. LDN should be discussed with a knowledgeable prescriber, as dosing protocols vary and compounding pharmacies are often required.

10. Neuromodulation Devices

Neuromodulation devices deliver targeted electrical stimulation to nerves involved in pain processing, aiming to disrupt the pain signals traveling between the gut and brain.

How they work

The most relevant device for functional abdominal pain is IB-Stim, which uses percutaneous electrical nerve field stimulation (PENFS) applied to the external ear. The ear contains branches of the vagus nerve and other cranial nerves that connect to brainstem pain-processing centers. By stimulating these nerve branches, the device aims to modulate the central pain circuits involved in CAPS.

What the evidence supports

IB-Stim received FDA clearance in 2019 for functional abdominal pain associated with IBS in adolescents, based on a sham-controlled trial of 115 patients showing greater reductions in worst pain after three weeks of treatment. In 2025, the clearance was expanded to patients aged 8 and older, including adults, and to functional dyspepsia, making it among the first devices cleared for functional dyspepsia.

Adult evidence is still emerging. A pilot sham-controlled trial in adult IBS (NCT04428619) has posted results, and additional trials of transcutaneous vagus nerve stimulation for visceral pain are ongoing.

Who it may help

Adults with CAPS who prefer non-pharmacological, non-behavioral options, or who want to add a complementary modality alongside behavioral therapy or medication. Neuromodulation devices are generally well-tolerated with minimal side effects.

How Lin Health Helps with Functional Abdominal Pain

Functional abdominal pain driven by central sensitization responds to treatment that targets the brain, not just the gut. That is exactly what Lin Health's program is designed to do.

Lin Health's approach is based on findings from neuroplastic pain research, including studies on pain reprocessing therapy, cognitive behavioral therapy, acceptance and commitment therapy, and emotional awareness and expression therapy. The program applies these principles through a structured, coach-led format that combines:

• Weekly live sessions with a trained recovery coach who specializes in persistent pain conditions
• A mobile app with learning modules, guided practices (including somatic tracking and graded exposure), and between-session support
• Multiple behavioral modalities woven into a single curriculum, so patients do not have to find separate providers for CBT, ACT, or PRT
• Chat-based support between sessions for questions, check-ins, and accountability

For patients with CAPS, the program addresses the fear-avoidance cycle, emotional processing, and learned pain patterns that maintain central sensitization. The goal is to help the nervous system's pain alarm reset, reducing both the intensity and frequency of abdominal pain over time.

Lin Health is covered by most major insurance plans in Colorado, Texas, Florida, California, and New York, with some coverage in additional states. Patients typically pay nothing out of pocket. Wait times are short, with most patients receiving a same-day callback after signing up.

If you have been living with functional abdominal pain and conventional GI treatments have not provided lasting relief, a brain-based approach may be worth exploring. Check your eligibility.

FAQ

What is centrally mediated abdominal pain syndrome (CAPS)?

CAPS is a gastrointestinal disorder classified under the Rome V criteria as a disorder of gut-brain interaction. It involves persistent abdominal pain driven by central sensitization in the nervous system rather than structural damage to the gut. Standard GI tests typically show no abnormalities.

How is CAPS different from IBS?

IBS involves abdominal pain related to changes in bowel habits (diarrhea, constipation, or both). In CAPS, the pain is continuous or near-continuous and not clearly connected to bowel movements, eating, or other physiological events. CAPS pain is considered more centrally driven.

Can CAPS be cured?

There is no single cure for CAPS, but many patients experience meaningful improvement with the right combination of treatments. Brain-based behavioral therapies and central neuromodulators have the strongest evidence for reducing pain and improving quality of life in adults with this condition.

Are opioids effective for CAPS?

Opioids are not recommended for CAPS. Clinical guidelines consistently advise against opioid use for functional GI disorders because opioids can worsen central sensitization and cause opioid-induced hyperalgesia, a condition in which pain sensitivity actually increases with chronic opioid use.

Does insurance cover treatment for CAPS?

Coverage depends on the treatment type and insurance plan. Central neuromodulators are typically covered as prescription medications. Coverage for behavioral therapies varies. Lin Health accepts most major insurance plans in several states, with most patients paying nothing out of pocket.

How long does treatment for CAPS take?

Most behavioral therapies (CBT, ACT, gut-directed hypnotherapy) involve 8 to 12 sessions over several months. Neuromodulators may take 4 to 6 weeks to show benefit. Many patients notice improvement within the first few weeks of a structured brain-based program, though full benefit often develops over 2 to 3 months.

Can I combine behavioral therapy with medication for CAPS?

Yes. The AGA recommends combining brain-gut behavioral therapies with central neuromodulators for adults with moderate-to-severe CAPS. Many clinicians find that behavioral approaches and medication address different aspects of the condition and work well together.

Is CAPS a real condition?

CAPS is a recognized medical diagnosis in both the Rome V classification system and the ICD-11 framework for chronic pain. The pain is real and measurable in brain imaging studies. It is not "in your head" in the dismissive sense, but it is generated and maintained by the central nervous system, which is why brain-targeted treatments have the strongest evidence base for this condition.

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, stopping, or changing any treatment plan. If you are experiencing severe or worsening abdominal pain, seek medical evaluation to rule out conditions requiring urgent care.